Correlation Between Ensysce Biosciences and Context Therapeutics

Can any of the company-specific risk be diversified away by investing in both Ensysce Biosciences and Context Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ensysce Biosciences and Context Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ensysce Biosciences and Context Therapeutics, you can compare the effects of market volatilities on Ensysce Biosciences and Context Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ensysce Biosciences with a short position of Context Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ensysce Biosciences and Context Therapeutics.

Diversification Opportunities for Ensysce Biosciences and Context Therapeutics

-0.18

Correlation Coefficient

Ensysce Biosciences  Context Therapeutics

Good diversification

The 3 months correlation between Ensysce and Context is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Ensysce Biosciences and Context Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Context Therapeutics and Ensysce Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ensysce Biosciences are associated (or correlated) with Context Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Context Therapeutics has no effect on the direction of Ensysce Biosciences i.e., Ensysce Biosciences and Context Therapeutics go up and down completely randomly.

Pair Corralation between Ensysce Biosciences and Context Therapeutics

Given the investment horizon of 90 days Ensysce Biosciences is expected to generate 5.01 times more return on investment than Context Therapeutics. However, Ensysce Biosciences is 5.01 times more volatile than Context Therapeutics. It trades about 0.09 of its potential returns per unit of risk. Context Therapeutics is currently generating about -0.12 per unit of risk. If you would invest  524.00  in Ensysce Biosciences on September 17, 2024 and sell it today you would earn a total of  117.00  from holding Ensysce Biosciences or generate 22.33% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.46%
Values	Daily Returns

Ensysce Biosciences  vs.  Context Therapeutics

Ensysce Biosciences

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Ensysce Biosciences are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent basic indicators, Ensysce Biosciences exhibited solid returns over the last few months and may actually be approaching a breakup point.

Context Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Context Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Ensysce Biosciences and Context Therapeutics

The main advantage of trading using opposite Ensysce Biosciences and Context Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ensysce Biosciences position performs unexpectedly, Context Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Context Therapeutics will offset losses from the drop in Context Therapeutics' long position.

The idea behind Ensysce Biosciences and Context Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.